Introduction
============

Difficulties in prediction and early identification of acute kidney injury (AKI) have hindered the ability to develop preventive and therapeutic measures for this syndrome. We tested the hypothesis that a urine test measuring insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2), both inducers of G~1~cell cycle arrest, a key mechanism implicated in AKI, could predict AKI in cardiac surgery patients.

Methods
=======

We studied 50 patients at high risk for AKI undergoing cardiac surgery with cardiopulmonary bypass. Serial urine samples were analyzed for \[TIMP-2\] × \[IGFBP7\] concentrations. The primary outcome measure was AKI as defined by international consensus criteria following surgery. Furthermore, we investigated whether urine \[TIMP- 2\] × \[IGFBP7\] could predict renal recovery from AKI prior to hospital discharge.

Results
=======

Twenty-six patients (52%) developed AKI. Diagnosis based on serum creatinine and/or oliguria did not occur until 1 to 3 days after cardiopulmonary bypass. In contrast, urine concentration of \[TIMP-2\] × \[IGFBP7\] rose from a mean of0.49 (0.24) at baseline to 1.51 (0.57) 4 hours after cardiopulmonary bypass in patients who developed AKI. The maximum urinary \[T\|MP-2\] × \[IGFBP7\] concentration achieved in the first 24 hours following surgery (composite time point) demonstrated an area under the receiver-operating characteristic curve of 0.84. Sensitivity was 0.92, and specificity was 0.81 for a cutoff value of 0.50. The decline in urinary \[TIMP-2\] × \[IGFBP7\] values was the strongest predictor for renal recovery.

Conclusion
==========

Urinary \[TIMP-2\] × \[IGFBP7\] serves as a sensitive and specific biomarker to predict AKI early after cardiac surgery and to predict renal recovery.
